Oxford Centre for Diabetes, Endocrinology and Metabolism
OCDEM is a pioneering centre that combines clinical care, research and education in diabetes, endocrine and metabolic diseases. By promoting world-class research, we aim to enhance understanding of these diseases and to accelerate the search for new treatments and cures.
TCF7L2 plays a complex role in human adipose progenitor biology, which might contribute to genetic susceptibility to type 2 diabetes.
VERMA M. et al, (2022), Metabolism: clinical and experimental
Age-dependent changes in protein incorporation into collagen-rich tissues of mice by in vivo pulsed SILAC labelling
Ariosa-Morejon Y. et al, (2021), eLife, 10
Li M. et al, (2021), Nature Communications, 12
Verkouter I. et al, (2021), The Journal of Clinical Endocrinology & Metabolism
Genetic variant effects on gene expression in human pancreatic islets and their implications for T2D.
Viñuela A. et al, (2020), Nat Commun, 11
Haythorne E. et al, (2019), Nat Commun, 10
Whole genome sequence analysis identifies a PAX2 mutation to establish a correct diagnosis for a syndromic form of hyperuricemia.
Stevenson M. et al, (2020), Am J Med Genet A
27 October 2021
The University of Oxford is part of a new international research network to investigate the interactions between the biology of the body's internal clock and the disordered physiological processes associated with stroke.
12 October 2021
This interactive and highly successful course returns to the face-to-face format in 3-7 April 2022 for its 18th year.
View previous and upcoming events in OCDEM.